Doseloop Beta

Other NAD+ precursors (e.g., nicotinamide mononucleotide)

supplement Under review

Nicotinamide mononucleotide (NMN) is a naturally occurring molecule that the body uses to make nicotinamide adenine dinucleotide (NAD+), a coenzyme involved in energy metabolism, mitochondrial function, and cellular maintenance. As people age, NAD+ levels tend to decline, which is one reason NMN has been studied as a potential way to support healthy aging and metabolic function. In healthy adults, NMN primarily works by raising circulating NAD+ levels after oral supplementation. Human studies have explored NMN for outcomes related to energy metabolism, exercise capacity, insulin sensitivity, and biomarkers of aging, but the clearest and most consistent finding is an increase in NAD+ rather than a proven clinical benefit across broad health outcomes.

Research summary

AI-Generated Content: This summary was created by AI and may contain errors. Always verify with peer-reviewed sources.

The human evidence base for NMN is still small and mostly short-term, but it does show that oral NMN reliably increases blood NAD+ in healthy adults. Across randomized trials and comparative human studies, NMN has been generally well tolerated, with no major safety signals in the healthy populations studied. However, evidence for downstream health benefits is limited and inconsistent. Some studies suggest possible improvements in specific metabolic or physical-performance measures in selected groups, but overall the research consensus is that NMN remains a promising NAD+ booster with established biomarker effects and still-unproven broader clinical benefits in healthy humans.

Reported Benefits

No side effects tracked yet

No side effects have been reported by studies or users for this habit yet.

Research (4 studies)

Systematic Review

The safety and antiaging effects of nicotinamide mononucleotide in humans

GeroScience • 2024

Yoshino et al.

Systematic Review

NAD(+) Precursors in Human Health and Disease: Current Status and Future Prospects.

Nutrients • 2023

Mouchiroud et al.

Systematic Review

Dietary Supplementation With NAD+-Boosting Compounds in Healthy Adults: A Review of Clinical Trials

Current Developments in Nutrition • 2023

Vinten et al.

RCT

The acute effect of different NAD+ precursors included in the combined metabolic activators

Metabolism • 2023

Yilmaz et al.

Community updates

No updates yet for this supplement.

Be the first to share your experience!

At a glance

Users tracking 0
Linked studies 4
Researched benefits 6
Side effects noted 0